Zymergen is a synthetic biology company that integrates automation, machine learning, and genomics to engineer microorganisms for industrial applications. Founded in 2013, it pioneered the concept of 'biofacturing' to create novel materials and chemicals before being acquired by Ginkgo Bioworks in 2022.